Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
2.
Case Rep Gastroenterol ; 2(3): 505-8, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21897807

RESUMEN

A 65-year-old man was admitted with penile tenderness and dysuria due to priapism. Enhanced computed tomography revealed metastatic tumors in the liver, lung, sacrum and lymph nodes. Advanced rectal cancer, detected by colonoscopy as a primary tumor, was treated with chemotherapy (FOLFOX4). Although the rectal cancer showed no change, five months of chemotherapy improveid the priapism, suggesting that chemotherapy can improve rare symptoms of rectal cancer.

3.
Am J Gastroenterol ; 93(3): 401-3, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9517648

RESUMEN

OBJECTIVE: We compared the ascitic fluid to serum bilirubin ratio with three other ways of classifying ascitic fluid to the categories of exudate or transudate: the serum-ascites albumin gradient, the total protein concentration of the fluid, and the adaptation of Light's criteria for the detection of pleural fluid exudate, i.e., fluid to serum protein or LDH ratio or fluid LDH concentration. (Recently it has been reported that the pleural fluid to serum bilirubin ratio is statistically equivalent to Light's criteria.) Also, we evaluated whether the addition of the bilirubin ratio to the other criteria increases their diagnostic accuracy. METHODS: Eighty-one specimens of ascitic fluid from 81 different patients were obtained. They were analyzed prospectively by SMA12, whereas the category of the fluid was determined according to the clinical diagnosis. The diagnostic accuracy of each criterion alone and in combination with the bilirubin ratio, with reference to the contended etiology, were evaluated. RESULTS: The best criterion is the albumin gradient (overall accuracy = 0.84). The bilirubin and LDH ratio criteria had equivalent overall accuracy (0.815 and 0.802, respectively). The addition of the bilirubin ratio to any criterion did not improve its predictive or overall accuracy. CONCLUSIONS: Ascitic fluid to serum bilirubin ratio is an additional marker for the distinction of transudate from exudate. A ratio > 0.6 has a statistically significant association with exudate.


Asunto(s)
Líquido Ascítico/química , Bilirrubina/análisis , Exudados y Transudados , Bilirrubina/sangre , Proteínas Sanguíneas/análisis , Humanos , L-Lactato Deshidrogenasa/análisis , Valor Predictivo de las Pruebas , Sensibilidad y Especificidad , Albúmina Sérica/análisis
4.
Br J Rheumatol ; 33(10): 977-80, 1994 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7921762

RESUMEN

The spectrum of the primary antiphospholipid syndrome has expanded in recent years. It has been associated with a number of non-thrombotic syndromes such as pulmonary hypertension, adrenal insufficiency, chorea and avascular necrosis of bone. Yet, it has not been described in association with inflammatory pulmonary disease. We describe a young male with definite primary antiphospholipid syndrome who developed insidious diffuse pulmonary infiltrates. The histopathologic examination of the involved lung demonstrated alveolitis and fibrosis. We suggest that this pulmonary involvement may represent another manifestation of the primary antiphospholipid syndrome.


Asunto(s)
Síndrome Antifosfolípido/complicaciones , Fibrosis Pulmonar/etiología , Adulto , Anticuerpos Antifosfolípidos/análisis , Síndrome Antifosfolípido/inmunología , Humanos , Masculino , Fibrosis Pulmonar/diagnóstico por imagen , Fibrosis Pulmonar/patología , Radiografía
5.
Cancer Chemother Pharmacol ; 23 Suppl: S87-9, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2538271

RESUMEN

Our multimodal treatment of hepatocellular carcinoma (HCC) has brought about a significant improvement of the survival rate. It consists of a combination of hepatectomy and transcatheter arterial embolization using lipiodol (L-TAE). In order to facilitate L-TAE, we have developed a special catheter with notches. A group of patients with HCC (124 cases), excluding cases with absolutely non-curative resections and operative deaths, were treated between December 1980 and November 1986. Each case was treated for more than 1 year after hepatectomy. The patients were divided into two groups: A, patients with a single tumor not larger than 5 cm, and B, cases with larger tumors or more than one lesion. Some patients in each group were treated with L-TAE after hepatectomy. In group A, there was no significant difference in survival between treated and non-treated cases. In group B, L-TAE gave a significantly better survival than no postoperative treatment.


Asunto(s)
Carcinoma Hepatocelular/terapia , Neoplasias Hepáticas/terapia , Carcinoma Hepatocelular/mortalidad , Terapia Combinada , Doxorrubicina/administración & dosificación , Embolización Terapéutica , Hepatectomía , Humanos , Neoplasias Hepáticas/mortalidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...